You searched for "CRS"

372 results found

Chronic rhinosinusitis, are we treating the same disease?

Chronic rhinosinusitis (CRS) is a heterogenic disease. The effects of heterogeneity on treatment outcome are not very clear. Authors used clinical features such as endoscopic findings scores and full blood count findings in addition to analysis of 35 molecular markers....

What do we put in our nasal douches? Anything?

The rise of the popularity of saline nasal douches, with several commercial preparations available, may be a rediscovery of an age-old tradition, but it has been shown to benefit patients. The question then arises as to whether this can be...

Objective versus subjective – again!

The use of objective measurements of nasal airflow has a long history; however, its clinical application remains, at most, patchy. The main reason for that has been the lack of convincing studies showing a good correlation between the findings of,...

How to manage the concha bullosa in FESS

It is an interesting concept to assess how much impact the presence of a large concha bullosa (CB) has on both severity of chronic rhinosinusitis (CRS) and also postoperative outcomes after FESS. The authors accept that the paper has limitations...

Location, location, location: How to get the steroid where you need it, in chronic rhinosinusitis

What almost all current guidelines on chronic rhinosinusitis have in common is the importance of intranasal steroid (INCS) use. However, it is increasingly understood that the efficacy of INCS depends on their efficient delivery to the point of need, i.e....

How much does FESS improve the sense of smell?

We are all familiar with patients who undergo a seemingly successful FESS but, in spite of this, have persistent smell dysfunction postoperatively. This study compares a surgical group with a control group, measuring olfactory function pre and postoperatively using Sniffin...

Endoscopic sinus surgery improves Eustachian tube dysfunction

This prospective, multicentre trial from China looked at the improvement in Eustachian tube function after endoscopic sinus surgery. Seventy patients from three tertiary units were included in the study. They all completed the Eustachian tube dysfunction (ETDQ-7) and SNOT-22 questionnaires...

Is there increased cardiovascular risk with macrolide antibiotics?

This month’s Ed’s Choice delightfully reviews the potential cardiovascular consequences of long-term macrolide use in the treatment of chronic rhinosinusitis. This used to be one of my ‘go-to’ topics of conversation at home after a bad day at work, although...

BRS Annual Meeting 2023

Edward Balai, ST4 Otolaryngology, Charing Cross Hospital. On a lovely sunny May morning in Winchester, the British Rhinological Society and ENT UK welcomed attendees to this two-day conference at the wonderful Guildhall. The BRS Juniors Annual Meeting was held in...

Welcome to ERS2023

For ERS2023, for the first time, the ERS board elected a scientific president to chair the scientific programme committee. The ERS board is very happy that Prof Paolo Castlenuovo was willing to take this task upon himself. Here he outlines...

BRS Annual Meeting and Juniors Day 2025

Will Tsang (ST1-3) BRS President Professor Peter Andrews opened the 2025 Annual Meeting in sunny Edinburgh, welcoming over 180 delegates — a record turnout. The programme was packed with speakers pushing the boundaries of modern rhinology.Highlights from day one included...

Evaluation of secondary otalgia

This Turkish prospective study of 200 patients looked at the pain characteristics of secondary otalgia related to temporomandibular disorders (TMD) and cervical region disorders (CRD), and how they can affect diagnostics. Patients were included if they were >18 years of...